About ArthroCare (NASDAQ:ARTC)
ArthroCare Corporation (ArthroCare) is a medical device company. ArthroCare develops and manufactures surgical devices, instruments, and implants. Its devices enable surgical procedures and enable new minimally invasive procedures. Many of ArthroCare's devices use its Coblation technology. This technology dissolves target tissue and limits damage to surrounding healthy tissue. ArthroCare also develops surgical devices utilizing other patented technology, including its OPUS line of fixation products, as well as re-usable surgical instruments. ArthroCare's two core product consists of sports medicine and ear, nose, and throat (ENT), as well as other areas, such as spine, wound care, urology and gynecology. It's Sports Medicine, ENT and other products are marketed and sold through two principal geographic distribution channels: Americas (North and South America) and International (all other geographies). In May 2014, Smith & Nephew PLC acquired the Company.
Industry, Sector and Symbol
Industry Advanced Medical Equipment & Technology
Sub-IndustryHealth Care Equipment
Trailing P/E RatioN/A
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on AssetsN/A
ArthroCare (NASDAQ:ARTC) Frequently Asked Questions
What is ArthroCare's stock symbol?
ArthroCare trades on the NASDAQ under the ticker symbol "ARTC."
Who are some of ArthroCare's key competitors?
Some companies that are related to ArthroCare include Thermo Fisher Scientific (TMO), Danaher (DHR), Intuitive Surgical (ISRG), Koninklijke Philips (PHG), Boston Scientific (BSX), Illumina (ILMN), Edwards Lifesciences (EW), Cerner (CERN), Agilent Technologies (A), Waters (WAT), ResMed (RMD), Hologic (HOLX), Varian Medical Systems (VAR), ABIOMED (ABMD), PerkinElmer (PKI), Sirona Dental Systems (SIRO), Bruker (BRKR) and Alere (ALR).
Who are ArthroCare's key executives?
ArthroCare's management team includes the folowing people:
- Gayle Wiley, Chief Human Resource Officer, Senior Vice President
- Jean A. Woloszko M.D., Ph.D., Senior Vice President - Research and Development, Chief Technology Officer (Age 56)
- Richard W. Rew II, Senior Vice President, General Counsel, Secretary (Age 49)
- Scott Schaffner, Senior Vice President, General Manager - Sports Medicine (Age 44)
- Fred B. Dinger III, Senior Vice President, General Manager of ENT
- James L. Pacek, Senior Vice President - Global Markets and Sales Operations (Age 65)
- Bruce C. Prothro, Chief Regulatory Officer, Senior Vice President - Quality Systems and Assurance (Age 52)
- Fabiana Lacerca-Allen, Independent Director (Age 47)
How do I buy ArthroCare stock?
Shares of ArthroCare can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact ArthroCare?
ArthroCare's mailing address is 7000 W William Cannon Dr, AUSTIN, TX 78735-8509, United States. The medical device company can be reached via phone at +1-512-3913900.
MarketBeat Community Rating for ArthroCare (ARTC)MarketBeat's community ratings are surveys of what our community members think about ArthroCare and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
ArthroCare (NASDAQ:ARTC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
ArthroCare (NASDAQ:ARTC) Earnings History and Estimates Chart
ArthroCare (NASDAQ ARTC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2014||Q313||$0.35||$0.32||$96.00 million||$96.06 million||View||N/A|
|2/13/2014||Q213||$0.40||$0.30||$100.53 million||$101.70 million||View||N/A|
|8/5/2013||Q2 2013||$0.34||($0.27)||$93.67 million||$92.10 million||View||Listen|
|5/7/2013||Q1 2013||$0.37||$0.30||$94.41 million||$92.30 million||View||Listen|
|2/13/2013||Q4 2012||$0.37||$0.30||$93.78 million||$96.90 million||View||Listen|
ArthroCare (NASDAQ:ARTC) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for ArthroCare (NASDAQ:ARTC)
No dividend announcements for this company have been tracked by MarketBeat.com
ArthroCare (NASDAQ ARTC) Insider Trading and Institutional Ownership History
ArthroCare (NASDAQ ARTC) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|1/9/2014||Jean Woloszko||SVP||Sell||32,627||$45.67||$1,490,075.09||40,511|| |
|1/8/2014||Barbara Boyan||Director||Sell||10,000||$45.00||$450,000.00||24,525|| |
|1/8/2014||Bruce Prothro||SVP||Sell||33,478||$45.82||$1,533,961.96||39,421|| |
|1/6/2014||Bruce Prothro||SVP||Sell||6,167||$39.75||$245,138.25||39,421|| |
|12/19/2013||Barbara Boyan||Director||Sell||10,000||$40.00||$400,000.00||24,525|| |
|12/19/2013||Jean Woloszko||SVP||Sell||10,657||$39.98||$426,066.86||46,193|| |
|10/30/2013||Jean Woloszko||SVP||Sell||1,342||$37.95||$50,928.90|| |
|10/7/2013||James Pacek||SVP||Sell||2,500||$34.48||$86,200.00||24,379|| |
|6/18/2013||Bruce Prothro||SVP||Sell||2,512||$36.00||$90,432.00|| |
|5/24/2013||Peter Wilson||Director||Sell||10,000||$33.36||$333,600.00|| |
|11/13/2012||David Fitzgerald||Director||Sell||25,000||$31.34||$783,500.00|| |
|8/7/2012||James G Foster||Director||Sell||35,000||$28.81||$1,008,350.00|| |
ArthroCare (NASDAQ ARTC) News Headlines
No headlines for this company have been tracked by MarketBeat.com
ArthroCare (NASDAQ:ARTC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
ArthroCare (NASDAQ:ARTC) Income Statement, Balance Sheet and Cash Flow Statement
ArthroCare (NASDAQ ARTC) Stock Chart for Wednesday, January, 17, 2018